Prior studies using human G55 cells have shown increased haemorrhaging using anti‐VEGF therapy in mice, and patients undergoing bevacizumab treatment have shown an increased risk of intracranial haemorrhaging.7, 12 We did not see any haemorrhaging in our pAb‐ nor mAb‐treated tumour regions on our MR images nor when stained with Prussian blue. This evidence concerns the gene VEGFA and neoplasm.